quantisnow
FeedTopReportsPricing
⌘K
Live feed
07:01:00·52d
PRRelease
Precision BioSciences Inc. logo
TG Therapeutics Inc. logo

Precision BioSciences Receives $7.5M in Proceeds from TG Therapeutics for Azer-cel Clinical Milestone in Multiple Sclerosis

DTIL· Precision BioSciences Inc.TGTX· TG Therapeutics Inc.
Health Care
Original source

Companies

  • DTIL
    Precision BioSciences Inc.
    Health Care
  • TGTX
    TG Therapeutics Inc.
    Health Care

Recent analyst ratings

  • Oct 6TGTXUpdateH.C. Wainwright$60.00
  • Jul 10TGTXUpdateGoldman$37.00
  • Jan 10DTILUpdateBMO Capital Markets$34.00
  • Oct 29TGTXUpdateTD Cowen$50.00
  • Apr 30DTILUpdateGuggenheim$19.00
  • Aug 2TGTXUpdateGoldman$12.00

Related

  • PR1d
    TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the American Academy of Neurology 2026 Annual Meeting
  • PR8d
    TG Therapeutics Announces Completion of Enrollment for the Phase 3 Trial Evaluating Subcutaneous BRIUMVI
  • SEC15d
    SEC Form DEFA14A filed by Precision BioSciences Inc.
  • SEC15d
    SEC Form DEF 14A filed by Precision BioSciences Inc.
  • PR15d
    Precision BioSciences to Participate in the 25th Annual Needham Virtual Healthcare Conference
  • SEC27d
    SEC Form PRE 14A filed by Precision BioSciences Inc.
  • SEC27d
    Amendment: SEC Form SCHEDULE 13G/A filed by TG Therapeutics Inc.
  • SEC34d
    TG Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022